Mitochondrial fitness and insulin sensitivity in humans
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Human mitochondria can be studied either in biopsies or by measuring flux through ATP synthase and phosphocreatine recovery using magnetic resonance spectroscopy. Myocellular ATP production (flux through ATP synthase [fATP]) increases by up to 90% during 8 h of insulin stimulation. Fasting mitochondrial function is 14-40% lower than in controls in the presence of insulin resistance, as seen in those with type 2 diabetes, their insulin-resistant relatives or the obese. Insulin-stimulated fATP is abolished in insulin-resistant relatives and patients with type 2 diabetes, and patients frequently show decreased mitochondrial size/density. Age, fat mass, physical activity, plasma NEFA and glucose all correlate negatively with mitochondrial function, but it is for methodological reasons difficult to determine whether reduced mitochondrial content or function account for reduced ATP production in insulin resistance. Experimental plasma NEFA elevation appears to inhibit mitochondrial function by interfering with the metabolic actions of insulin, which might explain impaired mitochondrial function in obesity. Alternatively, primary mitochondrial abnormalities, as seen in those with inherited risk of type 2 diabetes, could decrease lipid oxidation, thereby raising circulating and intracellular NEFA levels. In type 2 diabetes, chronic hyperglycaemia and dyslipidaemia could first diminish the function, and subsequently reduce the size or density of mitochondria via oxidative stress and apoptosis. Many questions remain unsolved, including (1) which mechanisms regulate mitochondrial adaptation to nutrient overload; (2) what factors control the expression of genes encoding mitochondrial proteins and other signals involved in mitochondrial biogenesis; (3) which geno/phenotypes are associated with both insulin resistance and mitochondrial abnormalities; and (4) which are the most promising targets for improving mitochondrial fitness in insulin resistance?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · cited 1×
“However, following intracellular uptake, NEFA can activate AMP-activated protein kinase (AMPK), which inactivates acetyl-CoA carboxylase and consequently decreases malonyl-CoA levels, thereby increasing lipid oxidation (Fig. 4). Hence, NEFA per se effectively facilitate intracellular lipid allocation [ 91 , 92].”
BackgroundLimiting factors for maximum oxygen uptake and determinants of endurance performance
BASSETT, D. R. (2000) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200001000-00012 · Cited by 2,410 · cited 1×
“The maximum AV pO2 difference during exercise may be produced by mitochondrial adaptation or by other muscular (myoglobin content, capillarisation) or systemic (blood flow stimulated by cardiorespiration and O2 delivery to non-muscular tissues) alterations [24].”
BackgroundDysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 3×
“insulin-resistant relatives of individuals with type 2 diabetes have a ∼30% lower fasting fATP, ∼80% higher intramyocellular lipid, but similar hepatocellular lipid levels compared with insulin-sensitive controls [ 41 ] (Table 1). These relatives also have reduced insulin-stimulated fATP and Pi transport into skeletal…”
BackgroundInfluentialMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 2×
“Interestingly, these older controls had a higher fATP than those in a previous study [ 40 ] that reported ∼50% lower fATP compared with young controls.”
BackgroundResultNonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990
Patti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952
Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248 · cited 1×
“In states of insulin resistance, impaired insulinstimulated glucose transport and/or phosphorylation, together with reduced glycogen synthesis, account for more than 50% of the reduction in whole body glucose disposal [1, 2 ].”
BackgroundKelley, D. E., Goodpaster, B., Wing, R. R., & Simoneau, J.-A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e1130 · Cited by 1,096
Uncoupling: new approaches to an old problem of bioenergetics
Skulachev, V. P. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(97)00091-1 · Cited by 893
Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., & Kelley, D. E. (2005) · Diabetes · doi:10.2337/diabetes.54.1.8 · Cited by 887
Etiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 2×
“Increased lipid availability will give rise to intracellular lipid metabolites such as long-chain fatty acyl-CoA (LCFA-CoA) which stimulate inflammatory pathways that interfere with insulin signal transduction, ultimately leading to insulin resistance [5].”
BackgroundMorino, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25151 · Cited by 811 · cited 3×
“The reason for the inconsistency between these studies might relate to the fact that the insulin-resistant relatives described in the latter study were young, lean and healthy [78], whereas the participants in the other studies were older, obese and diabetic.”
BackgroundResultThe role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
Petersen, K. F., Dufour, S., Savage, D. B., Bilz, S., Solomon, G., Yonemitsu, S., Cline, G. W., Befroy, D., Zemany, L., Kahn, B. B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705408104 · Cited by 759
Bays, H., Mandarino, L., & DeFronzo, R. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030723 · Cited by 664 · cited 1×
“Increased hepatocellular lipid content correlates negatively with both whole body and hepatic insulin sensitivity, and couldbethekeyfactorinthedevelopmentofinsulinresistance and type 2 diabetes [37, 38 ].”
BackgroundA signalling role for 4‐hydroxy‐2‐nonenal in regulation of mitochondrial uncoupling
Echtay, K. S., Esteves, T. C., Pakay, J. L., Jekabsons, M. B., Lambert, A. J., Portero‐Otín, M., Pamplona, R., Vidal‐Puig, A. J., Wang, S., Roebuck, S. J., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg412 · Cited by 597
Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes
Mogensen, M., Sahlin, K., Fernström, M., Glintborg, D., Vind, B. F., Beck-Nielsen, H., & Højlund, K. (2007) · Diabetes · doi:10.2337/db06-0981 · Cited by 573 · cited 1×
“Some groups have therefore tried to establish whether differences in proportions of fibre types could explain variation in mitochondrial function in type 2 diabetes, and increased proportions of type IIb fibres have been reported by several [67–69], though not all, studies [70].”
ResultEffect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle
Rooyackers, O. E., Adey, D. B., Ades, P. A., & Nair, K. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15364 · Cited by 564
Mitochondrial mutations may increase oxidative stress: Implications for carcinogenesis and aging?
Bandy, B., & Davison, A. J. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90152-9 · Cited by 550 · cited 1×
“Thus, oxidative capacity can be maintained in humans aged up to 70 years even though mtDNA accumulates mutations and deletions at high rates as a result of impaired DNA repair [51] and exposure to ROS [52].”
BackgroundAge and aerobic exercise training effects on whole body and muscle protein metabolism
Short, K. R., Vittone, J. L., Bigelow, M. L., Proctor, D. N., & Nair, K. S. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00366.2003 · Cited by 470 · cited 1×
“This method combines infusion of isotopically labelled amino acids with serial muscle biopsies and purification of mitochondria [15].”
MethodNair (2005) · doi:10.1093/ajcn/81.5.953 · Cited by 469
Befroy, D. E., Petersen, K. F., Dufour, S., Mason, G. F., de Graaf, R. A., Rothman, D. L., & Shulman, G. I. (2007) · Diabetes · doi:10.2337/db06-0783 · Cited by 453 · cited 1×
“can simultaneously assess oxidation/phosphorylation energy coupling by tracing the flux through the TCA cycle by monitoring 13 C incorporation into glutamate during continuous intravenous [ 13 C]acetate infusion [ 35 ].”
MethodSimoneau, J.-A., & Kelley, D. E. (1997) · Journal of Applied Physiology · doi:10.1152/jappl.1997.83.1.166 · Cited by 441
Guillet, C., Prod'homme, M., Balage, M., Gachon, P., Giraudet, C., Morin, L., Grizard, J., & Boirie, Y. (2004) · The FASEB Journal · doi:10.1096/fj.03-1341fje · Cited by 412 · cited 1×
“An age-related decline in mitochondrial function might be due to a reduction in overall and, in particular, insulin-stimulated protein synthesis [43–46], or be related to increasing body mass, insulin resistance and physical inactivity.”
BackgroundOxidative Capacity, Lipotoxicity, and Mitochondrial Damage in Type 2 Diabetes
Schrauwen, P., & Hesselink, M. K. C. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1412 · Cited by 408 · cited 1×
“proposed alternatively that during excess NEFA supply, a larger fraction enters the matrix via a transmembrane flip-flop mechanism as opposed to the CPT1 system [96, 97] (Fig.”
BackgroundZierath, J. R., He, L., Gumà, A., Wahlström, E. O., Klip, A., & Wallberg-Henriksson, H. (1996) · Diabetologia · doi:10.1007/bf02658504 · Cited by 402 · cited 1×
“Some groups have therefore tried to establish whether differences in proportions of fibre types could explain variation in mitochondrial function in type 2 diabetes, and increased proportions of type IIb fibres have been reported by several [67–69], though not all, studies [70].”
ResultMechanism of Amino Acid-Induced Skeletal Muscle Insulin Resistance in Humans
Krebs, M., Krssak, M., Bernroider, E., Anderwald, C., Brehm, A., Meyerspeer, M., Nowotny, P., Roth, E., Waldhäusl, W., & Roden, M. (2002) · Diabetes · doi:10.2337/diabetes.51.3.599 · Cited by 392
Self-citationMetabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study
Perseghin, G., Ghosh, S., Gerow, K., & Shulman, G. I. (1997) · Diabetes · doi:10.2337/diab.46.6.1001 · Cited by 367
Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes.
Krssak, M., Brehm, A., Bernroider, E., Anderwald, C., Nowotny, P., Man, C. D., Cobelli, C., Cline, G. W., Shulman, G. I., Waldhäusl, W., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.12.3048 · Cited by 313 · cited 1×
“Increased hepatocellular lipid content correlates negatively with both whole body and hepatic insulin sensitivity, and couldbethekeyfactorinthedevelopmentofinsulinresistance and type 2 diabetes [ 37 , 38].”
BackgroundPetersen, K. F., Dufour, S., & Shulman, G. I. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020233 · Cited by 308 · cited 4×
“Insulin stimulation has been reported to increase fATP in muscle mitochondria by 10–16% in vivo after 4 h and by 32–42% in vitro after 8 h [42, 43, 53 ].”
BackgroundMethodResultInfluentialSchrauwen-Hinderling, V. B., Kooi, M. E., Hesselink, M. K. C., Jeneson, J. A. L., Backes, W. H., van Echteld, C. J. A., van Engelshoven, J. M. A., Mensink, M., & Schrauwen, P. (2007) · Diabetologia · doi:10.1007/s00125-006-0475-1 · Cited by 304 · cited 4×
“1 19±3 [72]”
BackgroundMethodInfluentialGene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment
Sreekumar, R., Halvatsiotis, P., Schimke, J. C., & Nair, K. S. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1913 · Cited by 257 · cited 1×
“lation indicates that metabolic and endocrine control affect mitochondrial function [71].”
BackgroundWilson, J. R., Mancini, D. M., McCully, K., Ferraro, N., Lanoce, V, & Chance, B. (1989) · Circulation · doi:10.1161/01.cir.80.6.1668 · Cited by 256 · cited 2×
“It similarly reflects the dynamic balance between O2 delivery and extraction in the muscle capillary bed without being a direct measure of extraction [25].”
BackgroundMuscle Mitochondrial ATP Synthesis and Glucose Transport/Phosphorylation in Type 2 Diabetes
Szendroedi, J., Schmid, A. I., Chmelik, M., Toth, C., Brehm, A., Krssak, M., Nowotny, P., Wolzt, M., Waldhausl, W., & Roden, M. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040154 · Cited by 243 · cited 10×
“until a new equilibrium is reached [54, 55], and this immediate insulin effect on fATP might last for up to ∼ 4h [42, 43 , 56].”
BackgroundMethodInfluentialSelf-citationIncreased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle
Brehm, A., Krssak, M., Schmid, A. I., Nowotny, P., Waldhäusl, W., & Roden, M. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-1286 · Cited by 239
Self-citationEffect of growth hormone and resistance exercise on muscle growth and strength in older men
Yarasheski, K. E., Zachwieja, J. J., Campbell, J. A., & Bier, D. M. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.2.e268 · Cited by 234 · cited 1×
“Adjustment for physical activity might abolish differences in mitochondrial function between young and older persons [47, 48], since exercise stimulates the rate of muscle protein synthesis in both groups [49, 50].”
BackgroundAssociation of Oxidative Stress, Insulin Resistance, and Diabetes Risk Phenotypes
Meigs, J. B., Larson, M. G., Fox, C. S., Keaney, J. F., Vasan, R. S., & Benjamin, E. J. (2007) · Diabetes Care · doi:10.2337/dc07-0817 · Cited by 220 · cited 1×
“In line with this, a recent analysis demonstrated that systemic oxidative stress is related to insulin resistance in relatives of individuals with type 2 diabetes even after adjustment for BMI [79], but extended longitudinal studies of individuals at risk would be needed to prove causal relationships.”
Ukropcova, B., McNeil, M., Sereda, O., de Jonge, L., Xie, H., Bray, G. A., & Smith, S. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24332 · Cited by 213 · cited 1×
“Reduced activation of pyruvate dehydrogenase or impaired inhibition of carnitine palmitoyltransferase-1 (CPT1) complexes by insulin are examples of molecular disturbances that could be responsible for metabolic inflexibility [85, 86].”
BackgroundHeterogeneity of pig intestinal d-glucose transport systems
Halaihel, N., Gerbaud, D., Vasseur, M., & Alvarado, F. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.6.c1130 · Cited by 199
Hamilton, J. A. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200306000-00006 · Cited by 184
Roden, M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803102 · Cited by 149 · cited 1×
“Hyperglycaemia and impaired inhibition of lipolysis resulting from insulin resistance induced glucolipotoxicity which initiates a vicious cycle of metabolic decompensation, especially in association with a sedentary lifestyle and high-fat diet [ 7 ].”
BackgroundSelf-citationToledo, F. G. S., Watkins, S., & Kelley, D. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0002 · Cited by 126 · cited 1×
“In addition to decreased oxidative phosphorylation gene expression, altered mitochondrial size, number, function, localisation [9, 64, 78, 81] and generally reduced oxidative capacity [41, 43], defective adaptation mechanisms seem to play a pivotal role in mitochondrial dysfunction (Fig.”
BackgroundØrtenblad, N., Mogensen, M., Petersen, I., Højlund, K., Levin, K., Sahlin, K., Beck-Nielsen, H., & Gaster, M. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.04.001 · Cited by 101 · cited 1×
“Simultaneous addition of palmitate diminished the stimulatory effect of insulin in myotubes from controls, suggesting that NEFA-induced insulin resistance might interfere with insulin-stimulated mitochondrial function [80].”
BackgroundSchmid, A. I., Chmelík, M., Szendroedi, J., Krššák, M., Brehm, A., Moser, E., & Roden, M. (2008) · NMR in Biomedicine · doi:10.1002/nbm.1207 · Cited by 67 · cited 1×
“fATP in human liver, which yielded an fATP of ∼30 μmol (g liver) −1 min −1 in healthy young volunteers [ 36 ].”
BackgroundSelf-citationEnzyme activities in quadriceps femoris muscle of obese diabetic male patients
Vondra, K., Rath, R., Bass, A., Slabochov�, Z., Teisinger, J., & V�tek, V. (1977) · Diabetologia · doi:10.1007/bf01234508 · Cited by 48 · cited 1×
“citrate synthase, cytochrome c oxidase) enzyme activities in obese, physically inactive individuals, and persons with a family history of or with overt type 2 diabetes [63, 77, 83, 84].”
Background
Cited by
The role of mitochondria in insulin resistance and type 2 diabetes mellitus
Szendroedi, J., Phielix, E., & Roden, M. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.138 · Cited by 600
Self-citationThe Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 529
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293
Ectopic lipids and organ function.
Szendroedi, J., & Roden, M. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328321b3a8 · Cited by 200
Self-citationRichmond, R. C., Davey Smith, G., Ness, A. R., den Hoed, M., McMahon, G., & Timpson, N. J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001618 · Cited by 167
Metadata
- Authors
- Szendroedi, J., & Roden, M.
- Venue
- Diabetologia
- Published
- 2008-09-19
- Volume
- 51
- Issue
- 12
- Pages
- 2155-2167
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1998158504
- Cited by
- 71
- References
- 47
- FWCI
- 3.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.